Kantarjian H - Search Results

1

Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors.

Levis M, Brown P, Smith BD, Stine A, Pham R, Stone R, Deangelo D, Galinsky I, Giles F, Estey E, Kantarjian H, Cohen P, Wang Y, Roesel J, Karp JE, Small D. Levis M, et al. Among authors: kantarjian h. Blood. 2006 Nov 15;108(10):3477-83. doi: 10.1182/blood-2006-04-015743. Epub 2006 Jul 20. Blood. 2006. PMID: 16857987 Free PMC article.

2

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keating M. Estey E, et al. Among authors: kantarjian h. Blood. 1992 May 1;79(9):2246-55. Blood. 1992. PMID: 1571541 Free article.

3

Karyotype of leukemia cells consistently predicts for response to therapy and survival following salvage therapy in acute myeloblastic leukemia.

Keating MJ, Kantarjian H, Estey E, Plunkett W, Trujillo J, McCredie KB. Keating MJ, et al. Among authors: kantarjian h. Haematol Blood Transfus. 1990;33:593-603. doi: 10.1007/978-3-642-74643-7_109. Haematol Blood Transfus. 1990. PMID: 2182449 Review. No abstract available.

4

Clinical experience with fludarabine in leukaemia.

Keating MJ, Estey E, O'Brien S, Kantarjian H, Robertson LE, Plunkett W. Keating MJ, et al. Among authors: kantarjian h. Drugs. 1994;47 Suppl 6:39-49. doi: 10.2165/00003495-199400476-00007. Drugs. 1994. PMID: 7525188 Review.

5

Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.

Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Marlton P, et al. Among authors: kantarjian h. Leukemia. 1995 Jun;9(6):965-71. Leukemia. 1995. PMID: 7596186

6

Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.

Robertson LE, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating MJ. Robertson LE, et al. Among authors: kantarjian h. Leukemia. 1994 Dec;8(12):2047-51. Leukemia. 1994. PMID: 7807993

7

Topotecan in chronic lymphocytic leukemia.

O'Brien S, Kantarjian H, Ellis A, Zwelling L, Estey E, Keating M. O'Brien S, et al. Among authors: kantarjian h. Cancer. 1995 Mar 1;75(5):1104-8. doi: 10.1002/1097-0142(19950301)75:5<1104::aid-cncr2820750509>3.0.co;2-b. Cancer. 1995. PMID: 7850708 Clinical Trial.

8

Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.

Dimopoulos MA, O'Brien S, Kantarjian H, Estey EE, Keating MJ, Alexanian R. Dimopoulos MA, et al. Among authors: kantarjian h. Leuk Lymphoma. 1993;11 Suppl 2:105-8. doi: 10.3109/10428199309064269. Leuk Lymphoma. 1993. PMID: 7907250 Clinical Trial.

9

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders.

O'Brien S, Kurzrock R, Duvic M, Kantarjian H, Stass S, Robertson LE, Estey E, Pierce S, Keating MJ. O'Brien S, et al. Among authors: kantarjian h. Blood. 1994 Aug 1;84(3):733-8. Blood. 1994. PMID: 7913841 Free article. Clinical Trial.

10

What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?

Kantarjian H, Talpaz M, Estey E, Ku S, Kurzrock R. Kantarjian H, et al. Am J Med. 1994 Feb;96(2):133-8. doi: 10.1016/0002-9343(94)90133-3. Am J Med. 1994. PMID: 8109597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,503 results

Search Page